Cite

HARVARD Citation

    Martini, A. et al. (2019). Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer. Cancer. 125 (18), pp. 3155-3163. [Online]. 
  
Back to record